HK Stock MarketDetailed Quotes

C-MER MEDICAL (03309)

Watchlist
  • 1.270
  • -0.020-1.55%
Trading Apr 15 11:08 CST
1.54BMarket Cap15.30P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

C-MER MEDICAL (03309) Revenue Breakdown Overview

By Business/Source

Currency:HKD
2025/FY
Stock NameRevenueRatio
中国香港医疗业务948.73M48.73%
内地眼科业务520.33M26.73%
内地牙科业务459.83M23.62%
内地其他业务17.83M0.92%

By Product

Currency:HKD
2025/FY
Stock NameRevenueRatio
中国香港医疗业务948.73M48.73%
内地眼科业务520.33M26.73%
内地牙科业务459.83M23.62%
内地其他业务17.83M0.92%

By Country/Region

Currency:HKD
2025/FY
Stock NameRevenueRatio
The mainland of China997.98M51.27%
Hong Kong, China948.73M48.73%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 -0.47%
Sample Name
Sample Code
 -5.37%
Sample Name
Sample Code
 -6.31%
4
SHANGHAI PECHEM
00338
-10.56%
5
CNOOC
00883
-11.76%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.01%
Sample Name
Sample Code
 +21.11%
Sample Name
Sample Code
 +16.55%
4
Hangzhou Shunwang Technology
300113
+12.83%
5
Ucloud Technology Co., Ltd
688158
+10.50%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -